Mark Anderson

447 total citations
29 papers, 239 citations indexed

About

Mark Anderson is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Mark Anderson has authored 29 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Epidemiology and 11 papers in Hepatology. Recurrent topics in Mark Anderson's work include SARS-CoV-2 and COVID-19 Research (13 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). Mark Anderson is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). Mark Anderson collaborates with scholars based in United States, Cameroon and Germany. Mark Anderson's co-authors include Gavin Cloherty, Vera Holzmayer, Mary C. Kuhns, James N. Moy, Alan Landay, Lilia Cojuhari, Victor Pântea, Michel Bazinet, Pavlina Jimbei and Ulf Dittmer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Mark Anderson

26 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Anderson United States 8 152 123 96 30 21 29 239
Samir Dervisevic United Kingdom 7 95 0.6× 84 0.7× 117 1.2× 9 0.3× 6 0.3× 11 194
Robério Amorim de Almeida Pondé Brazil 12 275 1.8× 259 2.1× 67 0.7× 33 1.1× 16 0.8× 21 343
Irene Kyomuhangi United Kingdom 5 353 2.3× 341 2.8× 27 0.3× 21 0.7× 11 0.5× 9 409
Peter V. Markov United Kingdom 7 315 2.1× 325 2.6× 49 0.5× 19 0.6× 17 0.8× 10 389
Dylan Sheerin United Kingdom 8 40 0.3× 15 0.1× 74 0.8× 36 1.2× 38 1.8× 13 137
Luca Carioti Italy 9 124 0.8× 99 0.8× 109 1.1× 32 1.1× 9 0.4× 24 234
Wonderful T. Choga United States 8 126 0.8× 96 0.8× 91 0.9× 22 0.7× 9 0.4× 42 189
Haohui Deng China 8 86 0.6× 48 0.4× 55 0.6× 57 1.9× 15 0.7× 34 187
Y. Khudyakov United States 10 151 1.0× 259 2.1× 82 0.9× 36 1.2× 19 0.9× 15 294
Dulce Alfaiate France 8 315 2.1× 286 2.3× 50 0.5× 43 1.4× 23 1.1× 15 370

Countries citing papers authored by Mark Anderson

Since Specialization
Citations

This map shows the geographic impact of Mark Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Anderson more than expected).

Fields of papers citing papers by Mark Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Anderson. The network helps show where Mark Anderson may publish in the future.

Co-authorship network of co-authors of Mark Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Anderson. A scholar is included among the top collaborators of Mark Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Anderson. Mark Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Xiaoxing, Alessandro Olivo, Mark Anderson, et al.. (2024). Evaluation of a fully automated high-throughput serology assay for detection of Hepatitis D virus antibodies. Journal of Clinical Virology. 173. 105689–105689. 1 indexed citations
2.
Anderson, Mark, Vera Holzmayer, Barbara J. Harris, et al.. (2023). The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays. Journal of Clinical Virology. 166. 105532–105532. 1 indexed citations
3.
Anderson, Mark, Mary A. Rodgers, Alessandro Olivo, et al.. (2023). Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays. IJID Regions. 7. 277–280.
4.
Anderson, Mark, Ka‐Cheung Luk, Alessandro Olivo, et al.. (2023). Development and Validation of Three Automated High-Throughput Molecular Tests to Detect Monkeypox Virus Infections. The Journal of Infectious Diseases. 229(Supplement_2). S137–S143. 4 indexed citations
5.
Anderson, Mark, et al.. (2023). Measuring hepatitis B pgRNA stability using an updated automated HBV pgRNA assay with increased sensitivity. Hepatology Communications. 7(4). 7 indexed citations
6.
Rodgers, Mary A., Pir Ahmad Shah, Mark Anderson, et al.. (2023). Characterization of HBV surface antigen isoforms in the natural history and treatment of HBV infection. Hepatology Communications. 7(4). 6 indexed citations
7.
Holzmayer, Vera, et al.. (2023). Serological and Molecular Characterization of Occult HBV Infection in Blood Donors from South Italy. Viruses. 16(1). 71–71. 2 indexed citations
8.
9.
Butterfield, Tiffany R., et al.. (2022). SARS-CoV-2 Receptor-Binding Domain IgG Response to AstraZeneca (AZD1222) COVID-19 Vaccination, Jamaica. American Journal of Tropical Medicine and Hygiene. 106(5). 1511–1514. 3 indexed citations
10.
Haase, Michael, Mark Anderson, Gavin Cloherty, et al.. (2022). Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients. Journal of Nephrology. 35(5). 1467–1478. 14 indexed citations
11.
Anzinger, Joshua J., et al.. (2022). Prevalence of SARS-CoV-2 antibodies after the Omicron surge, Kingston, Jamaica, 2022. SHILAP Revista de lepidopterología. 2(4). 100124–100124. 1 indexed citations
12.
13.
14.
Anderson, Mark, et al.. (2021). Parvovirus enteritis in a raccoon (Procyon lotor). Brazilian Journal of Veterinary Pathology. 14(2). 137–141.
15.
Kuhns, Mary C., Vera Holzmayer, Anne L. McNamara, Mark Anderson, & Gavin Cloherty. (2021). Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers. Virology Journal. 18(1). 235–235. 10 indexed citations
16.
Ahouidi, Ambroise D., Mark Anderson, Moustapha Mbow, et al.. (2021). Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal. IJID Regions. 2. 96–98.
17.
Anderson, Mark, et al.. (2021). Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays. Journal of Clinical Virology. 141. 104855–104855. 6 indexed citations
18.
Anderson, Mark, et al.. (2021). SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine. JAMA Network Open. 4(8). e2119741–e2119741. 32 indexed citations
19.
Bazinet, Michel, Mark Anderson, Victor Pântea, et al.. (2021). Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy. Hepatology Communications. 5(11). 1873–1887. 15 indexed citations
20.
Bazinet, Michel, Victor Pântea, Valentin Cebotarescu, et al.. (2020). Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection. Hepatology Communications. 5(2). 189–202. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samir Dervisevic Breakdown of academic impact, for papers by Robério Amorim de Almeida Pondé Breakdown of academic impact, for papers by Irene Kyomuhangi Breakdown of academic impact, for papers by Peter V. Markov Breakdown of academic impact, for papers by Dylan Sheerin Breakdown of academic impact, for papers by Luca Carioti Breakdown of academic impact, for papers by Wonderful T. Choga Breakdown of academic impact, for papers by Haohui Deng Breakdown of academic impact, for papers by Y. Khudyakov Breakdown of academic impact, for papers by Dulce Alfaiate
Rankless by CCL
2026